Chief Science Officer, National Pharmaceutical Council, Jon Campbell, PhD

from Perspectives by the Leerink Center for Pharmacoeconomics · host The Leerink Center for Pharmacoeconomics

Melanie Whittington, Head of the Leerink Center for Pharmacoeconomics, interviews Jon Campbell, Chief Science Officer of the National Pharmaceutical Council, to discuss what makes biopharmaceutical innovation special and why judging and interpreting their prices is nuanced and requires context.

Episode metadata supplied by the publisher feed · Published May 21, 2025

Embed this episode

Attribution link and audio player

Ready to play

Chief Science Officer, National Pharmaceutical Council, Jon Campbell, PhD

0:00 33:20

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Perspectives by the Leerink Center for Pharmacoeconomics?

This episode is 33 minutes long.

When was this Perspectives by the Leerink Center for Pharmacoeconomics episode published?

This episode was published on May 21, 2025.

Can I download this Perspectives by the Leerink Center for Pharmacoeconomics episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!